Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis
Year: 2025
Type: article
Language: en
Topic: Acute Myeloid Leukemia Research
Authors and affiliations:
raw_author_name: Huimin Jin
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Zhen Guo
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Liying Zhu
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Fei Huang
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Yujie Wu
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Hairong Qiu
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Yan Wang
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Yuemin Gong
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Guangsheng He
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Lei Fan
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Zhongxun Shi
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
raw_author_name: Wenyi Shen
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
raw_author_name: Chun Qiao
raw_affiliation_strings: Collaborative Innovation Center for Cancer Personalized Medicine  Nanjing China
Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital  Nanjing China
Key Laboratory of Hematology of Nanjing Medical University  Nanjing China
Department of Hematology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China